Using cryoablation as first-line therapy in patients with newly diagnosed, paroxysmal atrial fibrillation can significantly reduce the risk of recurrence measured by continuous arrhythmia monitoring ...

BARCELONA, SPAIN—For patients with paroxysmal and persistent atrial fibrillation (AF), delaying catheter ablation for 12 months while optimizing antiarrhythmic drug therapy has no impact on arrhythmia ...

Genetic testing may be considered in patients with early-onset atrial fibrillation (AF), particularly those with a positive family history and lack of conventional clinical risk factors, because ...

However, it remains unclear with these clinical benefits can be extrapolated to patients with stable heart failure, particularly heart failure with preserved ejection fraction (HFpEF), and whether ...

Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation, compared with usual care, early rhythm control therapy reduced risk for ...

Sophia Antipolis, 27 March 2023: Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared ...